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A LETTER FROM IOWA 
 
Dear Healthcare Provider, 
 
Thank you for participating in Iowa’s Breast and Cervical Cancer Early Detection Program. If you are reading this 
manual, you know that screening and early cancer detection is an important step in helping live longer, healthier 
lives. 
  
This manual will help you and your agency effectively participate in our program. It will help you understand the 
Breast and Cervical Cancer component of the Care for Yourself program.  
 
Your work is important in helping underserved Iowans receive the cancer screenings they need while reducing 
barriers to screening. 
 
We wish you and your agency success in engaging with this program to increase the breast and cervical cancer 





Jill Myers Geadelmann, BS, RN 
Chronic Disease Prevention and Management Bureau Chief  
Iowa Department of Public Health  
  
PROGRAM BACKGROUND 
Since 1995, the Care for Yourself – Breast and Cervical Cancer Program (BCC Program) has served Iowans as part 
of the Center for Disease Control and Prevention’s National Breast and Cervical Cancer Early Detection Program. 
 
 The program’s goal is to decrease cancer burden through prevention, early detection and timely follow-up.  
 
Through a decentralized program structure, local Boards of Health across Iowa elect to participate in the 
program, providing patient navigation and service delivery for underserved Iowans. Every local program has at 
least one staff person trained on the Care for Yourself program. This person is called the local program 
coordinator. The local program coordinators find, recruit and refer individuals to direct screening at a local 
health system.  
 
The priority focus of the program is to: 
 
 Maintain a network of healthcare providers to support screening service availability and delivery 
 Provide access to screening and diagnostic services for program-eligible individuals 
 Provide patient navigation to guide participants through the healthcare continuum  
 Reach individuals who have never or have rarely been screened for breast and cervical cancer  
 Reduce over-screening for cervical cancer 
 
 
THE PROGRAM PROVIDES SERVICES FOR: 
 Individuals age 40 and over 
 Individuals under age 40 with symptoms of breast cancer 
 Transgender women taking hormones 
 Transgender men who have not had a bilateral mastectomy or total hysterectomy 
 All participants must have a household income less than 250 percent of the federal poverty level1 
 
 
ENROLLMENT PROCESS  
 
To enroll a patient in the BCC Program, please contact your local program coordinator. A service area map with 




                                                 
1 Current income guidelines are available at the program website: www.idph.iowa.gov/CFY 
2 Appendix I or Contact A Program Near You www.idph.iowa.gov/CFY/public.  
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YOUR ROLE AS A HEALTHCARE PROVIDER 
As a healthcare provider participating in the Breast and Cervical Cancer Program, you must: 
 Review the Healthcare Provider Manual  
 Be licensed or certified to practice in the state where participants are served 
 Provide appropriate breast and cervical cancer screening, diagnostic and treatment services according 
to program policies and protocols 
 Follow the evidence-based guideline for cervical abnormalities published by the American Society of 
Colposcopy and Cervical Pathology (ASCCP)3  
 Immediately and confidentially report exam results and recommended follow-up to the Care for 
Yourself local program coordinator upon receipt of results4 
 Ensure your Health System and/or Clinic is an enrolled facility  
All laboratories must have current certification with the Commission on Office Laboratory Accreditation (COLA) 
or the Clinical Laboratories Improvement Act (CLIA). Pap test results should follow the current The Bethesda 
System of Pap test classification.  
All mammography facilities must be certified by the US Food and Drug Administration-approved certifying body 
under the Mammography Quality Standards Act (MQSA) of 1992. The American College of Radiology (ACR) 
Breast Imaging Lexicon will be used to report the interpretation of mammography examinations. 
 
BECOMING AN ENROLLED FACILITY 
Every facility interested in participating in the Breast and Cervical Cancer Program must complete enrollment 
paperwork. Your organization, as defined by Tax ID number, must complete one Cooperative Agreement with 
the Iowa Department of Public Health. The Cooperative Agreement is valid for six years, after which it will need 
to be renewed. Each individual facility, as defined by address, must complete one Service Facility Application. 
This form includes facility and billing information necessary for claims processing and reimbursement. One clinic 
NPI number should be used for all claims; use of individual provider NPI numbers use should be avoided. In 
addition, a current W-9 and CLIA or COLA certificate should be included if applicable.  
The Cooperative Agreement and Service Facility Application can be requested by emailing Gena Hodges at 
Gena.Hodges@idph.iowa.gov. For efficiency, please use a subject line of “BCC Application.” 
  
                                                 
3 2012 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities can be found at 
http://www.asccp.org/management-guidelines.  
4 As a public health surveillance and intervention program according to Public Law 104-191, Sec 1178(b) the Iowa Care for 
Yourself Breast and Cervical Cancer Program is exempt from HIPAA regulations. See Appendix III. 
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The BCC Program encourages individuals to obtain regular cancer screening services. All office visits for program 
participants must include appropriate breast and cervical cancer screening, including the following: 
 Two blood pressure measurements taken at least two minutes apart 
 Height and weight measurements 
 Clinical breast exam 
 Pelvic exam 
 Mammography, as recommended by the provider5 
 Pap test, per program protocol5 
 Breast and/or cervical diagnostic services5, as recommended by the provider 
 Referral for pre-cancer and cancer treatment, as recommended by the provider 
 Tobacco cessation referral 
 
Please reference the approved ICD-10 and CPT Service Codes6 listing for the current fiscal year. The BCC program 
will only pay for approved services.  
 
FOLLOW-UP SERVICES 
SHORT-TERM FOLLOW UP 
Short-term follow-up is the repeat of an examination earlier than normally recommended by program 
guidelines. 
The BCC Program protocol requires short-term follow-up for the following: 
 
 
Screening Service Short-Term Follow Up 
Clinical Breast Exam Based on healthcare provider recommendation 
Mammogram BIRADS Category III (probably benign) 




                                                 
5 See Appendix II- Program Screening Service Guidelines and Screening Follow-up Adequacy  
6 Information for Healthcare Providers www.idph.iowa.gov/CFY/information-for-healthcare-providers  
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DIAGNOSTIC FOLLOW UP 
 
Diagnostic follow-up refers to the examinations after abnormal screening results to determine a specific 
diagnosis. Program-eligible individuals over the age of 40 may be referred to the BCC Program after an abnormal 
screening result, even if they were not a program participant for the initial screening.  
 
The BCC Program requires diagnostic testing for the following conditions: 
 Clinical Breast Exam (CBE) Results  
o Abnormality – Suspicious for cancer (i.e., discrete mass [cystic or solid], bloody or 
serous nipple discharge, skin dimpling or retraction, nipple areolar scaliness). A 
diagnostic procedure(s) and final diagnosis must be reported.7 
o A normal mammogram does not mean an abnormal CBE can be ignored. Further 
action must be taken. 
 Mammogram Results – BIRADS  
o Category IV – Suspicious abnormality 
o Category V – Highly suggestive of malignancy 
o   Category 0 – Assessment Incomplete – Need additional imaging evaluation 
Assessment Incomplete – Film comparison needed 
 Pap Test Results – diagnostic follow-up should be done following the American Society for 




The BCC Program provides limited reimbursement for the following diagnostic services: 
 
Breast Diagnostics: 
 Surgical visit for repeat CBE 
 Diagnostic mammogram 
 Biopsy/lumpectomy 
 Ultrasound 
 Fine needle/stereotactic/cyst aspiration biopsy 
 Pathology consult during surgery 
 Anesthesia time 
 Breast MRI (preauthorization required)  
 
Cervical Diagnostics: 
 Specialty referral  
 Colposcopy (with/without biopsy) 
 LEEP (preauthorization required)  
 Cold Knife Cone (preauthorization required) 
 
 Endometrial biopsy (preauthorization required)  
 Pathology  
 
                                                 
7 Follow diagnostic options for an abnormal CBE endorsed by the Commission on Cancer of the American College of 
Surgeons, the American College of Obstetrics and Gynecology or the National Cancer Institute. 




REIMBURSEMENT FOR SERVICES AND CLAIM SUBMISSION 
Federal law requires that reimbursement with federal funds may not exceed Iowa Medicare Part B rates. 
Medicare and BCC Program reimbursement rates are updated annually after the rates are released by the 
Centers for Medicare and Medicaid Services (CMS). Updated information is available on the Care for Yourself 
website.9 Program reimbursement rates are to be accepted as payment in full, and facilities will not bill 
individual patients or the BCC Program for any additional costs.  
Reimbursement of claims will be processed up to one year (12 months) from the date of service. Claims 
exceeding the 12-month period from the date of service will be denied. As a reminder, no participant in the BCC 
Program should be billed for any covered service; however, the participant may be billed for services not 
covered by the BCC Program. The participant must be made aware before the service is provided that the 
screening program will not cover the procedure and that the cost will be the participant's responsibility. 
Medical Billing Services (MBS) processes and reimburses claims for the Breast and Cervical Cancer Program. All 
reimbursements for the Breast and Cervical Cancer Program will be paid by MBS doing business as "Iowa 
Screening Programs." Questions regarding claims should be directed to MBS at 515-237-3974. 
Electronic claim submission is encouraged, and only 837p (professional claims) will be accepted electronically. 
Please provide your clearinghouse with the following information: 
The payer ID information is:  
TriZetto Provider Solutions  
One Financial Plaza  
501 N. Broadway, 3rd Floor, St. Louis, MO 63102 
More information can be found on the Care for Yourself website.9  
  
                                                 
9 Information for Healthcare Providers www.idph.iowa.gov/CFY/information-for-healthcare-providers 
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ADDITIONAL PROGRAM COMPONENTS  
MEDICAL ADVISORY BOARD 
A Medical Advisory Board offers guidance and assistance to the IA BCC Program. Members represent various 
program specialties, including breast surgeon, oncologist gynecologist, pathologist, mammography technician, 
women’s health and family practice. Please contact the program at 1-866-339-7909 if you are interested in 
becoming a member of this board.  
 
TECHNICAL ASSISTANCE AND PROFESSIONAL EDUCATION  
State and local BCC Program staff are available to provide orientation and training about this program for 
healthcare facilities’ staff. Contact your local BCC Program coordinator or call 1-866-339-7909. 
Program changes and updates can be found on the Care for Yourself website10.  
 
QUALITY ASSURANCE AND QUALITY IMPROVEMENT 
Quality assurance and quality improvement are integral components of the BCC Program and contribute to the 
program’s success. The purpose of quality assurance and improvement is to: 
 Ensure the quality of services delivered through the program 
 Monitor performance and identify opportunities for improvement 
 Plan effective strategies for improving services 
Program requirements and monitoring activities include: 
 Reporting standards for radiological, laboratory and pathology – reports must be reported according to 
national standards 
 Standards for adequacy of follow-up – data reports track appropriate and timely diagnostic, short-term 
and rescreening services 
 Patient navigation services – local program staff evaluate needs, implement plans and refer participants 
who need additional services 
 Accurate data and documentation – Specific data elements are reported to Centers for Disease Control 
and Prevention (CDC) semi-annually 
 Evaluation – reports are completed routinely and as needed to assess how well the BCC Program is 
meeting CDC goals 
 Adherence to CDC policies and guidelines  
                                                 
10 www.idph.iowa.gov/CFY  
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BREAST AND CERVICAL CANCER TREATMENT 
Eligibility for Referral to the IA Breast and Cervical Cancer Treatment (BCCT) Option of Medicaid 
1. An individual is eligible for the BCCT option of Medicaid if they: 
a. Are not covered by a mandatory category of Medicaid 
b. Have not reached age 65 
c. Received breast or cervical cancer screenings or related diagnostic services provided or funded by: 
i. a National Breast and Cervical Cancer Early Detection Program 
ii. family planning centers 
iii. community health centers  
iv. non-profit organizations 
d. Do not have creditable insurance coverage for breast or cervical cancer or pre-cancer treatment  
2. The individual must meet the income eligibility requirements established by the BCC Program. 
3. The individual must be diagnosed with a pre-cancerous/cancerous breast or cervical condition and require 
treatment for the cancer. 
Responsibilities of Healthcare Providers 
1. Notify local or state BCC Program staff of the diagnosis. 
2. Validate that the enrolled/referred individual is diagnosed with pre-cancerous or cancerous breast or 
cervical condition(s). 
3. Send a copy of the pathology report with the breast or cervical diagnosis to the BCC Program staff at the 
same time as the notification. 
4. Provide Department of Human Services (DHS) staff with appropriate participant information upon request. 
** Steps 1 and 3 facilitate participant referral for treatment coverage under the BCCT option of Medicaid. The 
quicker these steps are accomplished the quicker an individual without creditable insurance can start breast or 
cervical cancer treatment. 
Once BCC Program staff are notified, they will: 
1. Assess the individual for eligibility for the BCCT Medicaid option. 
2. Assist the eligible individual to apply for the BCCT option of Medicaid. 
3. Provide DHS staff the necessary documentation. DHS staff are responsible for making the final 
determination of eligibility. 
An individual enrolled in the BCCT option of Medicaid will receive full Medicaid benefits for the duration of the 
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BCC PROGRAM SCREENING SERVICES GUIDELINE 
Iowa Care For Yourself - BCC Program Screening Services 
Age 
Blood Pressure, Height, 
Weight 
Clinical Breast Exam Mammogram Pelvic/Pap test11 
Under 
40 
ONLY if reporting 
symptoms of breast 
cancer12 
ONLY if reporting 
symptoms of 
breast cancer 
ONLY if CBE is 
abnormal 
ONLY if reporting 
symptoms of 
breast cancer 


























Participants over age 64 who do not have Medicare Part B and meet income guidelines will receive 







                                                 
11  Refer to: Recommendations and Rationale for Cervical Cancer Screening Protocol. 
12 Examples of breast cancer symptoms include but are not limited to an abnormal CBE, breast skin dimpling or retraction, 
palpable mass or nipple discharge, inversion or scaliness. 
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ALGORITHM FOR BREAST CANCER SCREENING FOLLOW-UP ADEQUACY13 
CBE RESULT MAMMOGRAM RESULT DIAGNOSTIC PROCEDURES REQUIRED FOR ADEQUACY14 
Normal/Benign 
(including fibrocystic, 
lumpiness or nodularity) 
 Negative 
 Benign 
 Probably Benign (Short 
term follow-up indicated) 
 No work-up required 
 If work-up is planned, at least one diagnostic 
procedure must be done and a final diagnosis 
recorded 
 Suspicious Abnormality One or more of the following: 
 Surgical consult for repeat breast exam 
 Ultrasound 
 Biopsy/Lumpectomy 
 Fine Needle/Cyst Aspiration 
 Assessment Incomplete One or more of the following: 
 Additional mammography views 
Ultrasound 
 Highly Suggestive of 
Malignancy 
One or more of the following: 
 Biopsy/Lumpectomy 
Fine Needle/Cyst Aspiration 
Abnormal 
(suspicious for cancer) 
 Negative 
 Benign 
 Probably Benign (Short 
term follow-up indicated) 
 Assessment Incomplete 
One or more of the following: 
 Surgical consult for repeat breast exam 
 Ultrasound 
 Biopsy/Lumpectomy 
 Fine Needle/Cyst Aspiration 
 Note: A mammogram or additional mammogram views 
only are not considered adequate 
 Suspicious Abnormality 
 Highly Suggestive of 
Malignancy 
One or more of the following: 
 Biopsy/Lumpectomy 
 Fine Needle/Cyst Aspiration 
 Highly Suggestive of 
Malignancy 
One or more of the following: 
 Biopsy/Lumpectomy 
 Fine Needle/Cyst Aspiration 
                                                 
13 This algorithm is inappropriate as a tool for clinical decision-making for individuals to determine whether certain 
providers are performing according to accepted national practices. 
14 Clinical interventions based on clinical guidelines endorsed by the Commission on Cancer of the American College of 




ALGORITHM FOR CERVICAL CANCER SCREENING FOLLOW-UP ADEQUACY15 
NOTE: Pap Specimen Adequacy must be “Satisfactory” for Pap test results to be recorded.  
PAPANICOLAOU (PAP) TEST RESULT 
DIAGNOSTIC PROCEDURES REQUIRED FOR ADEQUACY16 
BETHESDA (TBS) 2001 
Negative for Intraepithelial Lesion or Malignancy  No work-up required 
ASC-US  (Atypical Squamous Cells – Undetermined 
Significance) 
 No work-up required, but follow-up at one year required 
 If HPV test negative, co-testing follow-up at 3 years 
 If HPV test positive, colposcopy required 
 If work-up is planned, colposcopy must be done 
Low Grade SIL encompassing: 
 HPV 
 Mild Dysplasia/CIN 1 
One or more of the following: 
 Negative HPV, repeat co-testing at 1 year 
 Negative HPV, colposcopy (with or without biopsy) 
 No or Positive HPV, colposcopy (with or without biopsy) 
ASC-H  (Atypical Squamous Cells – Cannot exclude 
High Grade Squamous Intraepithelial Lesion [SIL]) 
One or more of the following: 
 Colposcopy 
 Colposcopy with biopsy 
High Grade SIL encompassing (with features 
suspicious for invasion): 
 Moderate & Severe Dysplasia 
 CIS/CIN 2 & CIN 3 
One or more of the following: 
 Colposcopy 
 Colposcopy with biopsy 
 Loop Electrode Excision Procedure17 
 Conization 17 
Squamous Cell Carcinoma 
One or more of the following: 
 Colposcopy 
 Colposcopy with biopsy 
Abnormal Glandular Cells 
Adenocarcinoma in situ (AIS) 
Adenocarcinoma 
One or more of the following: 
 Colposcopy 
 Colposcopy with biopsy 
 Cold knife Conization 17 
 Endometrial Biopsy 17 
 
PRIMARY HUMAN PAPILLOMAVIRUS (HPV) SCREENING ALGORITHM 
HPV TEST RESULT DIAGNOSTIC PROCEDURES REQUIRED FOR ADEQUACY 
Negative   Routine Screening 
12 Other High Risk HPV (hrHPV) Positive 
 Cytology Required 
 If Pap test negative, HPV test in 12 months 
 If Pap Test greater than or equal to ASC-US, colposcopy required 
Type 16/18 Positive  Colposcopy 
                                                 
15 This algorithm is inappropriate as a tool for clinical decision making for individuals or to determine if certain providers are 
performing according to accepted national practices. 
16  Clinical interventions based on the American Society for Colposcopy and Cervical Pathology’s 2012 Algorithms from the 
Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. 




HIPAA PRIVACY RULES AND THE RELEASE OF INFORMATION 
 
